TG THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TG THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $46.30M.
- TG THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was -$1.00K.
- TG THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $165.04M, a 1500281.82% increase year-over-year.
- TG THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $11.00K.
- TG THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $462.23M, a 496.62% increase from fiscal 2019.
- TG THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2019 was $77.47M, a 31.82% decline from fiscal 2018.
- TG THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2018 was $113.64M, a 111.85% increase from fiscal 2017.
- TG THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2017 was $53.64M, a 1122.98% increase from fiscal 2016.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-06-30 | $46.30M 10-Q · filed 2024-11-07 | |
| 2020-12-31 | $462.23M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$1.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $165.04M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $77.47M 10-K · filed 2022-03-01 | |
| 2019-06-30 | $11.00K 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $27.50M 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $113.64M 10-K · filed 2020-03-02 | |
| 2017-12-31 | $53.64M 10-K · filed 2020-03-02 | |
| 2016-12-31 | $4.39M 10-K · filed 2019-03-01 | |
| 2015-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $750.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | -$2.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $750.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $750.00K 10-Q · filed 2015-05-11 | $750.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $16.79M 10-K · filed 2017-03-16 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $16.79M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | |
| 2014-03-31 | $16.79M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $37.65M 10-K · filed 2016-03-15 |
| 2012-12-31 | $12.18M 10-K · filed 2014-03-07 | |
| 2012-03-31 | $12.18M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $9.66M 10-K · filed 2014-03-07 | |
| 2010-12-31 | $2.59M 10-Q · filed 2011-11-14 | |
| 2007-12-31 | $7.85M 10-Q · filed 2011-11-14 | |
| 2005-12-31 | $12.25M 10-Q · filed 2011-11-14 | |
| 2004-12-31 | $3.36M 10-Q · filed 2011-11-14 | |
| 2003-12-31 | $743.69K 10-Q · filed 2011-11-14 | |
| 2002-12-31 | $1.70M 10-Q · filed 2011-11-14 | |
| 2001-12-31 | $0.00 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |